Enavate Sciences
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio2 active
2Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: AirNexis Therapeutics
8Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| AirNexis Therapeutics | Biotech | Active | Mar 9, 2026 | $62.0M |
| Normunity | Biotech | Active | — | — |
| Ambros Therapeutics | Biotech | Acquired | — | — |
| Braveheart Bio | Biotech | Public | — | — |
Peer ranks
Portfolio size#108
Portfolio exits#103
Raises, 12 months#22
Co-investors#173
Co-investors
- Frazier Healthcare PartnersVenture capital2 shared
- OrbiMedVenture capital2 shared
- Andreessen HorowitzVenture capital1 shared
- ForbionVenture capital1 shared
- General CatalystVenture capital1 shared
- Goldman Sachs AlternativesVenture capital1 shared
- Mission BioCapitalVenture capital1 shared
- RA CapitalVenture capital1 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.